Marilena Vrana: Securing Sustainable Plasma Supply for Europe’s Growing Patient Needs
Marilena Vrana, Vice President at the Plasma Protein Therapeutics Association (PPTA) Europe, shared a post on LinkedIn:
“I was glad to join with my PPTA colleagues Anita Brikman, James Knowles and Halide Tuna, the 2026 IPFA/EBA Symposium on Plasma Collection and Supply in Leuven this week.
The discussions focused on both progress and ongoing challenges in meeting plasma need for the growing patient need for plasma-derived medicines, including immunoglobulins and other life-saving and life-enabling therapies.
During the exchanges with peers, I emphasized that ‘self-sufficiency’ should be addressed through a multi-stakeholder dialogue that includes patients and physicians. It must be viewed through the lens of European strategic autonomy – not only national capacity and self-sufficiency – and grounded in actual patient need.
While patient need is still not comprehensively recorded across all Member States, data show that it continues to grow steadily in Europe and globally, driven by improved diagnostic technologies, new indications, and evolving disease detection strategies.
Ensuring patients’ long-term peace of mind requires that we align policy ambition with real-world demand.
There is a clear opportunity for more aligned strategies across stakeholders – from streamlining contract fractionation arrangements to strengthening resilient supply chains that better serve patients in Europe and beyond.
Stronger public-private partnerships, supported by data and best practices, will be critical to closing availability gaps and advancing our collective responsibility to secure long-term sustainability of supply.
I look forward to continuing the dialogue at PPC2026 in Milan – an important checkpoint for our community – where the private sector’s role in strengthening Europe’s Resilience, Reach and Responsibility in plasma and plasma derived medicines will be further discussed.
Together, we can continue moving faster and further in delivering for all patients.”

Find more posts featuring Marilena Vrana on Hemostasis Today.
-
Apr 4, 2026, 18:08Anirban Sen Gupta: Dante Disharoon’s Research on PlateChek Featured on JTH April 2026 Cover
-
Apr 4, 2026, 18:06Domenico Girelli: WHO 2024 Guidelines Reveal Higher Global Anemia Burden and Epidemiological Shift
-
Apr 4, 2026, 18:04Fotios Barkas: Exploring The Bidirectional Relationship Between Frailty and Stroke
-
Apr 4, 2026, 17:56Marc Turner: VETERANSFirst, CHAMPION-AF Trial, and HI-PEITHO Trial Driving Innovation at ACC26
-
Apr 4, 2026, 17:55Julian Kyoung-Ryul Chun: The Largest Dataset on Embolic Complications after AF Is Out
-
Apr 4, 2026, 17:54Marie Dragoy: Insights from Norway on Helicopter Emergency Services in Suspected Stroke Care
-
Apr 4, 2026, 17:53Julia Shapranova: Connecting Neuroscience with The Reality of Clinical Trials Leadership and Management at ESOC 2026
-
Apr 4, 2026, 17:51Filippo Cademartiri: The DECIDE Registry Tackles a Critical Gap In Cardiovascular Care
-
Apr 4, 2026, 17:51Rabiah Alnoshan: A Pactical, Bedside Focused Approach to Bleeding